These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12867135)

  • 1. Cognitive enhancement raises ethical concerns. Academics urge pre-emptive debate on neurotechnologies.
    Butcher J
    Lancet; 2003 Jul; 362(9378):132-3. PubMed ID: 12867135
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of methylphenidate among medical students: a systematic review.
    Finger G; Silva ER; Falavigna A
    Rev Assoc Med Bras (1992); 2013; 59(3):285-9. PubMed ID: 23680277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Use of Methylphenidate for Cognitive Enhancement in Young Healthy Adults: The Clinical and Ethical Debates.
    Koren G; Korn L
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):100-102. PubMed ID: 33666399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The implications of methylphenidate use by healthy medical students and doctors in South Africa.
    Beyer C; Staunton C; Moodley K
    BMC Med Ethics; 2014 Mar; 15():20. PubMed ID: 24592964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does methylphenidate influence cognitive performance?
    Solanto MV
    J Am Acad Child Adolesc Psychiatry; 1997 Oct; 36(10):1323-5. PubMed ID: 9334541
    [No Abstract]   [Full Text] [Related]  

  • 6. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.
    Leonard BE; McCartan D; White J; King DJ
    Hum Psychopharmacol; 2004 Apr; 19(3):151-80. PubMed ID: 15079851
    [No Abstract]   [Full Text] [Related]  

  • 7. Cognitive event-related potentials in populations at risk for substance abuse.
    Herning RI
    NIDA Res Monogr; 1996; 159():161-85; discussion 186-92. PubMed ID: 8784859
    [No Abstract]   [Full Text] [Related]  

  • 8. Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement.
    Forlini C; Racine E
    BMC Med Ethics; 2009 Jul; 10():9. PubMed ID: 19580661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroenhancement in healthy subject? A French case study].
    Micoulaud-Franchi JA; Vion-Dury J; Lancon C
    Therapie; 2012; 67(3):213-21. PubMed ID: 22874487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moral perspectives on stimulant use by healthy students.
    Verster GC; van Niekerk AA
    S Afr Med J; 2012 Oct; 102(12):909-11. PubMed ID: 23498034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenidate, modafinil, and caffeine for cognitive enhancement in chess: A double-blind, randomised controlled trial.
    Franke AG; Gränsmark P; Agricola A; Schühle K; Rommel T; Sebastian A; Balló HE; Gorbulev S; Gerdes C; Frank B; Ruckes C; Tüscher O; Lieb K
    Eur Neuropsychopharmacol; 2017 Mar; 27(3):248-260. PubMed ID: 28119083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount.
    Banjo OC; Nadler R; Reiner PB
    PLoS One; 2010 Dec; 5(12):e14322. PubMed ID: 21179461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of methylphenidate among students: the future of enhancement?
    Outram SM
    J Med Ethics; 2010 Apr; 36(4):198-202. PubMed ID: 20338928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive enhancement or impairment? A systematic meta-analysis of prescription stimulant effects on processing speed, decision-making, planning, and cognitive perseveration.
    Marraccini ME; Weyandt LL; Rossi JS; Gudmundsdottir BG
    Exp Clin Psychopharmacol; 2016 Aug; 24(4):269-84. PubMed ID: 27454675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of methylphenidate-induced tolerance on cognition by buspirone co-administration.
    Alam N; Najam R; Khan SS
    Pak J Pharm Sci; 2015 Sep; 28(5):1601-5. PubMed ID: 26408868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylphenidate does not improve cognitive function in healthy sleep-deprived young adults.
    Bray CL; Cahill KS; Oshier JT; Peden CS; Theriaque DW; Flotte TR; Stacpoole PW
    J Investig Med; 2004 Apr; 52(3):192-201. PubMed ID: 15222409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychostimulant Use for Neuroenhancement (Smart Drugs) among College Students in Brazil.
    de Oliveira Cata Preta B; Miranda VIA; Bertoldi AD
    Subst Use Misuse; 2020; 55(4):613-621. PubMed ID: 31790311
    [No Abstract]   [Full Text] [Related]  

  • 18. Methylphenidate: established and expanding roles in symptom management.
    Prommer E
    Am J Hosp Palliat Care; 2012 Sep; 29(6):483-90. PubMed ID: 22144657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroenhancers, addiction and research ethics.
    Shaw DM
    J Med Ethics; 2012 Oct; 38(10):605-8. PubMed ID: 22888151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of methylphenidate on the cognitive and personality functioning of ADHD children.
    Lufi D; Parish-Plass J; Gai E
    Isr J Psychiatry Relat Sci; 1997; 34(3):200-9. PubMed ID: 9334525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.